teladoc glp-1 receptor agonist weight management diabetes treatments How Agonists Evolved from to Loss GLP-1 Drug Savings: A Complete

SeptemberOctober 2016

Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I: SAVOR-TIMI 53 Steering Committee and Investigators

RM is an educational advisor for Nestle Nutrition and Fresenius Kabi

Introduction In the past decade, obesity and related co-morbidities have become critical public health problems and serious medical conditions worldwide (1)

Chin Med J (Engl) (2012) 125(8):145764

22 Long-term safety data remain limited, warranting cautious consumption pending comprehensive toxicological studies